The global Automated Patch Clamp System Market is estimated to be valued at US$ 503.32 Mn or Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Automated patch clamp is a platform used for electrophysiology research and ion channel screening. It enables high-throughput characterization of ion channels and receptors through automation. This offers advantages such as high data reproducibility and efficiency compared to manual patch clamp technique.
Market key trends:
One of the key trends in the automated patch clamp system market is the increasing adoption of these systems in drug discovery. Automated patch clamp systems are increasingly being utilized by pharmaceutical companies for screening new drug candidates during the drug discovery and development process. They help screen large libraries of chemical compounds for their effects on ion channels and receptors. This is done to understand the mechanisms of drug action and identify potential drug candidates at an early stage. The high-throughput capability of these systems allows screening of thousands of compounds per day, thereby improving efficiency and reducing costs for pharmaceutical companies.
Market key trends:
One of the key trends in the automated patch clamp system market is the development of high-throughput systems. There has been a rise in demand for high-throughput screening of ion channels for drug discovery. This has fueled the demand for automated patch clamp systems with higher throughput capabilities. System manufacturers are focusing on improving the throughput of their existing systems or developing new systems with significantly higher throughput. For instance, in 2021, Molecular Devices launched its FLIPR Torque HTS system featuring 50% higher throughput over the previous generation for high throughput screening of ion channels.
Strength: Automated patch clamp systems offer high throughput capabilities, precision and reproducibility as compared to manual patch clamp technique. This facilitates screening of large ion channel libraries rapidly.
Weakness: High costs associated with automated patch clamp systems limits their adoption by small laboratories and research organizations.
Opportunity: Growing drug discovery research in pharmaceutical companies and increasing R&D investments in ion channel drug targets present significant growth opportunities.
Threats: Presence of alternative technologies like fluorescence-based membrane potential assays and multi-electrode arrays for drug screening poses competition.
The Global Automated Patch Clamp System Market Demand is expected to witness high growth, exhibiting CAGR of 11% over the forecast period, due to increasing focus on developing safer and more effective drugs for treating conditions like cardiac arrhythmia and neurological disorders.
Regionally, North America followed by Europe dominated the automated patch clamp system market and accounted for over 65% share of the global market in 2022. However, Asia Pacific is expected to witness fastest growth due to rising investments by pharmaceutical companies in new drug development in countries like China and India.
Key players operating in the automated patch clamp system market are Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH. In recent years, major players have launched innovative high throughput systems to strengthen their market position.